Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

Group 1 - Lyell Immunopharma, Inc. is a clinical-stage company focused on developing next-generation CAR T-cell therapies for cancer patients [1][2] - The company utilizes advanced technologies to enhance CAR T cells, enabling them to resist exhaustion and function effectively in challenging tumor microenvironments [2] - Upcoming investor conferences include the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference on February 25 and TD Cowen's 45th Annual Health Care Conference on March 3 [3] Group 2 - The company is headquartered in South San Francisco, California, with additional facilities in West Hills, California, and Seattle and Bothell, Washington [2] - A live webcast of the presentations will be available on the company's website, with replays accessible afterward [1]